These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 32843628)

  • 1. A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2.
    Zhao H; To KKW; Sze KH; Yung TT; Bian M; Lam H; Yeung ML; Li C; Chu H; Yuen KY
    Nat Commun; 2020 Aug; 11(1):4252. PubMed ID: 32843628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses.
    Zhao H; Zhou J; Zhang K; Chu H; Liu D; Poon VK; Chan CC; Leung HC; Fai N; Lin YP; Zhang AJ; Jin DY; Yuen KY; Zheng BJ
    Sci Rep; 2016 Feb; 6():22008. PubMed ID: 26911565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
    Xiong R; Zhang L; Li S; Sun Y; Ding M; Wang Y; Zhao Y; Wu Y; Shang W; Jiang X; Shan J; Shen Z; Tong Y; Xu L; Chen Y; Liu Y; Zou G; Lavillete D; Zhao Z; Wang R; Zhu L; Xiao G; Lan K; Li H; Xu K
    Protein Cell; 2020 Oct; 11(10):723-739. PubMed ID: 32754890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor.
    Cao N; Cai Y; Huang X; Jiang H; Huang Z; Xing L; Lu L; Jiang S; Xu W
    mBio; 2024 May; 15(5):e0074124. PubMed ID: 38587427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus.
    Al-Beltagi S; Preda CA; Goulding LV; James J; Pu J; Skinner P; Jiang Z; Wang BL; Yang J; Banyard AC; Mellits KH; Gershkovich P; Hayes CJ; Nguyen-Van-Tam J; Brown IH; Liu J; Chang KC
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33546185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment.
    Hoffmann J; Schneider C; Heinbockel L; Brandenburg K; Reimer R; Gabriel G
    Antiviral Res; 2014 Apr; 104():23-33. PubMed ID: 24486207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of influenza A virus infection in vitro by peptides designed in silico.
    López-Martínez R; Ramírez-Salinas GL; Correa-Basurto J; Barrón BL
    PLoS One; 2013; 8(10):e76876. PubMed ID: 24146939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses.
    Lu S; Pan X; Chen D; Xie X; Wu Y; Shang W; Jiang X; Sun Y; Fan S; He J
    Bioorg Chem; 2021 Feb; 107():104619. PubMed ID: 33450541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target.
    Yuan S; Chu H; Huang J; Zhao X; Ye ZW; Lai PM; Wen L; Cai JP; Mo Y; Cao J; Liang R; Poon VK; Sze KH; Zhou J; To KK; Chen Z; Chen H; Jin DY; Chan JF; Yuen KY
    Sci Adv; 2020 Aug; 6(35):eaba7910. PubMed ID: 32923629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of stachyflin on influenza A viruses of different hemagglutinin subtypes.
    Motohashi Y; Igarashi M; Okamatsu M; Noshi T; Sakoda Y; Yamamoto N; Ito K; Yoshida R; Kida H
    Virol J; 2013 Apr; 10():118. PubMed ID: 23587221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.
    Li Q; Zhao Z; Zhou D; Chen Y; Hong W; Cao L; Yang J; Zhang Y; Shi W; Cao Z; Wu Y; Yan H; Li W
    Peptides; 2011 Jul; 32(7):1518-25. PubMed ID: 21620914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PA Endonuclease Inhibitor RO-7 Protects Mice from Lethal Challenge with Influenza A or B Viruses.
    Jones JC; Marathe BM; Vogel P; Gasser R; Najera I; Govorkova EA
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells.
    Jones JC; Turpin EA; Bultmann H; Brandt CR; Schultz-Cherry S
    J Virol; 2006 Dec; 80(24):11960-7. PubMed ID: 17005658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo.
    Perwitasari O; Johnson S; Yan X; Howerth E; Shacham S; Landesman Y; Baloglu E; McCauley D; Tamir S; Tompkins SM; Tripp RA
    J Virol; 2014 Sep; 88(17):10228-43. PubMed ID: 24965445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2.
    Jang Y; Shin H; Lee MK; Kwon OS; Shin JS; Kim YI; Kim CW; Lee HR; Kim M
    Sci Rep; 2021 Jan; 11(1):821. PubMed ID: 33436985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-functional peptide with defective interfering genes effectively protects mice against avian and seasonal influenza.
    Zhao H; To KKW; Chu H; Ding Q; Zhao X; Li C; Shuai H; Yuan S; Zhou J; Kok KH; Jiang S; Yuen KY
    Nat Commun; 2018 Jun; 9(1):2358. PubMed ID: 29907765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses.
    Weston S; Baracco L; Keller C; Matthews K; McGrath ME; Logue J; Liang J; Dyall J; Holbrook MR; Hensley LE; Jahrling PB; Yu W; MacKerell AD; Frieman MB
    Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30687-30698. PubMed ID: 33184176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo.
    Narayan R; Sharma M; Yadav R; Biji A; Khatun O; Kaur S; Kanojia A; Joy CM; Rajmani R; Sharma PR; Jeyasankar S; Rani P; Shandil RK; Narayanan S; Rao DC; Satchidanandam V; Das S; Agarwal R; Tripathi S
    Cell Rep Med; 2023 Aug; 4(8):101127. PubMed ID: 37463584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferon.
    Ortigoza MB; Dibben O; Maamary J; Martinez-Gil L; Leyva-Grado VH; Abreu P; Ayllon J; Palese P; Shaw ML
    PLoS Pathog; 2012; 8(4):e1002668. PubMed ID: 22577360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants.
    Zhao H; Meng X; Peng Z; Lam H; Zhang C; Zhou X; Chan JF; Kao RYT; To KK; Yuen KY
    Emerg Microbes Infect; 2022 Dec; 11(1):926-937. PubMed ID: 35259078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.